Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA Inc.
Docket No. | Op. Below | Argument | Opinion | Vote | Author | Term |
---|---|---|---|---|---|---|
17-1229 | Fed. Cir. | Dec 4, 2018 | Jan 22, 2019 | 9-0 | Thomas | OT 2018 |
Holding: The sale of an invention to a third party who is obligated to keep the invention confidential may place the invention "on sale" for purposes of the Leahy-Smith America Invents Act, which bars a person from receiving a patent on an invention that was "in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention," 35 U.S.C. § 102(a)(1).
Judgment: Affirmed, 9-0, in an opinion by Justice Thomas on January 22, 2019.
SCOTUSblog Coverage
- OT2018 #16: "From Scratch" (First Mondays, January 28, 2019)
- Opinion analysis: Justices affirm ruling that secret sales of invention bar later patent (Ronald Mann, January 22, 2019)
- Argument analysis: Justices debate revised language in patent-priority statute (Ronald Mann, December 5, 2018)
- Argument preview: Of patents, prior art and secret sales (Ronald Mann, November 27, 2018)
- Court sends battles over services for same-sex couples, North Carolina gerrymandering back to lower courts (Updated) (Amy Howe, June 25, 2018)
- Petition of the day (Aurora Barnes, April 12, 2018)